Environmental exposures have been recognized as critical in the initiation and exacerbation of asthma, one of the most common chronic childhood diseases. The National Institute of Allergy and Infectious Diseases; National Institute of Environmental Health Sciences; National Heart, Lung, and Blood Institute; and Merck Childhood Asthma Network sponsored a joint workshop to discuss the current state of science with respect to the indoor environment and its effects on the development and morbidity of childhood asthma. The workshop included US and international experts with backgrounds in allergy/allergens, immunology, asthma, environmental health, environmental exposures and pollutants, epidemiology, public health, and bioinformatics. Workshop participants provided new insights into the biologic properties of indoor exposures, indoor exposure assessment, and exposure reduction techniques. This informed a primary focus of the workshop: to critically review trials and research relevant to the prevention or control of asthma through environmental intervention. The participants identified important limitations and gaps in scientific methodologies and knowledge and proposed and prioritized areas for future research. The group reviewed socioeconomic and structural challenges to changing environmental exposure and offered recommendations for creative study design to overcome these challenges in trials to improve asthma management. The recommendations of this workshop can serve as guidance for future research in the study of the indoor environment and on environmental interventions as they pertain to the prevention and management of asthma and airway allergies. Many trials aiming to improve asthma outcomes by altering the indoor environment have been conducted over the past 2 decades in response to observational studies suggesting that indoor environmental exposures influenced childhood asthma incidence and morbidity. The National Institutes of Health's National Institute of Allergy and Infectious Diseases, National Institute of Environmental Health Sciences, and National Heart, Lung, and Blood Institute, in collaboration with the Merck Childhood Asthma Network, sponsored a joint workshop to discuss the current state of science with respect to the indoor environment and its effects on the development and morbidity of childhood asthma. The workshop included US and international experts from a variety of relevant disciplines and addressed the unmet need to critically review environmental intervention asthma trials aiming at reducing asthma incidence and improving asthma control. In addition, workshop participants discussed indoor exposure assessment methodologies and the biologic properties of allergens and indoor pollutants as they relate to the risk of asthma and asthma morbidity and the possible protective effects of some of those exposures. This report, authored by all participants, presents the deliberations of the workshop with specific recommendations for current research needs in the field. The workshop was held in 2014, but all authors contributed current updates in both recommendations and key publications. The authors hope that the report will stimulate the next generation of scientific projects and clinical trials related to the role of the environment in childhood asthma and respiratory allergy.
NEW INSIGHTS INTO INDOOR EXPOSURE ASSESSMENT
The indoor environment contains numerous exposures with the potential to influence asthma development and morbidity. Exposures include biologics (allergens, bacteria, or fungi), pollutant gases, and particulate matter from indoor (eg, gas stoves and cigarette smoke) and outdoor sources. Infiltrating ambient particulate matter contains a heterogeneous mix of inorganic, organic, and biologic components. 1,2 Indoor particle sampling can include collection of house dust (vacuumed or swiped from surfaces) or air samples (collected actively or by passive settling). Experience with nasal samplers and other personal monitoring devices for assessment of bioaerosol inhalation exposure is limited. [3] [4] [5] The gold standard for measurement of exposure to individual allergens in dust or air samples has been the ELISA, which has been improved by reduction of assay time and use of amplification to increase sensitivity. In the past decade, for standardized measurement of multiple allergens in epidemiologic studies, the ELISA has largely been replaced by fluorescent multiplex array technology, with measurements shown to be reproducible within and between laboratories. [6] [7] [8] New laboratory approaches, advances in field sampling equipment, and real-time data monitoring, including rapid tests for allergens, [9] [10] [11] might provide insight into the spectrum of indoor exposures (Table I) . [6] [7] [8] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] Technologies for allergen measurement, including quantitative PCR (qPCR), mass spectrometry, and allergen biosensors, are in development, including those supported by the National Institutes of Health (NIH) Pediatric Research using Integrated Sensor Monitoring Systems program. 29 Mass spectrometry has been used as a high-sensitivity method for detection of grass pollen allergens and is also being evaluated for food allergen detection. [12] [13] [14] A first generation of allergen biosensors can measure levels of Der p 1, Der p 2, Asp f 1, and Ara h 1, and advances in personal air sampling methodology have led to new insight into critical allergen exposure locations. [15] [16] [17] [18] For the characterization of indoor microbial communities in dust and air, before the availability of culture-independent technology-enabling metagenomics, environmental microbial taxa were measured by means of either culture, qPCR of select taxa, or quantification of the presence or activity of bioactive indoor pathogen-associated molecular patterns. Gram-negative bacterial endotoxin bioactivity has been quantified by using both kinetic Limulus amebocyte lysate and recombinant Factor C assays. [30] [31] [32] Endotoxin and the gram-positive pathogen-associated molecular pattern biomarker peptidoglycan (N-acetyl muramic acid) have been also measured by using gas chromatography/mass spectrometry. These methods are now complemented by culture-independent metagenomic characterization of communities of microbes originating from a multitude of sources (eg, human subjects, pets, mice, cockroaches, dust mites, water, soil, plants, and building materials). 33, 34 Amplification and sequencing of select regions (16S rDNA for bacteria and 18S or ITS for fungi) of rDNA, the gene that encodes for ribosomal RNA, yields information on the taxonomic composition of the environmental microbiome. [19] [20] [21] [22] [23] [24] [33] [34] [35] [36] Alternatively, rDNA microarrays can be used to characterize bacterial taxonomic abundance. Microarrays are less agnostic than rDNA sequencing and might require larger quantities of 16S rDNA. 25 Whole-genome shotgun sequencing of all DNA extracted from an environmental sample also yields information on taxonomic composition of bacteria, fungi, and viruses, although depth of coverage might be less than for rDNA amplification and sequencing. It also provides characterization of potential function through metagenomics estimation of the proportion of genes detected for given microbial metabolic pathways. 26 All of these metagenomic techniques generate relative abundance data for taxonomic composition or representation of functional pathways but do not measure total bacterial or fungal microbial load, a task that requires qPCR. Also, they do not adequately address the actual function of household bacteria and the relevance to that function to metabolic products (including breakdown of household chemicals) that could influence human health or to colonization of the human microbiome. 
Research priorities

Allergens
Fluorescent multiplex array [6] [7] [8] Bead-based fluorescent suspension array allows for simultaneous detection of up to 11 allergens. Also being developed for food allergens Biosensors [15] [16] [17] [18] Variety of sensor technologies (AAO film, gold nanoparticle, magnetic beads, DNA-stem loop probe) High sensitivity; could be smart phone enabled for personal exposure measures Mass spectrometry [12] [13] [14] Fragmentation of analyte and quantification of mass to charge units Methods developed for grass pollen and food allergens High sensitivity, but high throughput capacity is limited; measurements are expensive. Bacteria 16S rDNA microarrays 25 Requires higher quantities (;500 ng) of 16S rDNA compared with sequencing Broad range of taxa identifiable, but some rare microorganisms might be missed. 16S rDNA sequencing [19] [20] [21] [22] [25] [26] [27] 16S rDNA is amplified and sequenced. 41, 42 Human and in vitro laboratory studies have suggested a variety of adverse or protective airway responses to inhaled allergens modulated by coexposure to natural adjuvants (eg, bacterial components) that depend on dose, timing of exposure, and host characteristics. In some mouse models endotoxin was found to be the primary adjuvant in common house dust for promoting T H 17 responses and neutrophilic inflammation characteristic of steroidresistant asthma, but this microbial product was dispensable for priming the T H 2 responses associated with allergic asthma. 43 In contrast, bacterial flagellin stimulated strong T H 2 responses to ovalbumin and was an important adjuvant component in some samples of house dust. 44 Thus in mouse models microbial ligands found in house dust can act in a dose-dependent manner to direct discrete types of immune responses to inhaled allergens. 45, 46 Human studies support this general notion that concomitant exposure to allergens and microbes can shape the type of immune response that develops to the allergen. 33, 34, 43, 44 Allergen and microbial exposures can interact with each other and with pollutants, leading to harmful or, in certain cases, beneficial immunologic and clinical effects. 47, 48 Tobacco smoke and other inhalant toxins appear to alter epithelial cell gene expression throughout the respiratory tract and are likely to be important cofactors in immune response to allergens and perpetuation of asthma. 38 Metabolites of microbes and other organisms can also act as adjuvants. For example, chitin, a polysaccharide in allergens, fungi, and insects, has been shown to be an adjuvant for T H 2 responses. 45, 46, 49 The effects of allergens, adjuvants, and other environmental stimuli on the human airway epithelium can be studied in vitro with the use of primary cell cultures. Nasal brushing yielding upper airway respiratory epithelial cells from the inferior turbinate offers targeted opportunities for epigenetic and gene expression characterization of airway responses potentially relevant to asthma and allergic rhinitis. 50 Although it is a minimally invasive procedure, nasal brushing is perceived to have variable levels of comfort/discomfort by children and adults. 51 A recent study suggests that gene expression responses to tobacco smoke in the nasal epithelium correlate well with that in lower airway epithelial cells. 52, 53 Population-level studies of allergen exposure Although the prospective relation of home allergen levels to allergy development has been well-studied in specific birth cohorts, including those with clinical trial designs, the National Survey of Lead and Allergens in Housing and National Health and Nutrition Examination Survey 2005-2006 were the first US population-level studies of cross-sectional associations between allergen exposures, allergic conditions, and sensitization. 54, 55 These surveys indicated that almost half of the US population was sensitized to aeroallergens and that exposure to multiple allergens in homes was common. Although many prospective and cross-sectional studies show adverse associations of allergens or their sources with allergic sensitization, wheeze, or asthma, protective associations have also been found with exposures to animal allergens or their mammalian sources [56] [57] [58] [59] [60] and in 1 multicity disadvantaged urban US cohort study to multiple allergens, including cockroaches and dust mites. 34 Collectively, these findings underscore the need to understand time windows of susceptibility to allergic sensitization and the complex dose-response relationships between allergen exposure, other heritable or environmental coexposures (eg, stress and pollutants), and sensitization. Air pollutants found indoors that can trigger asthma symptoms originate from outdoor (eg, traffic) and indoor (eg, secondhand smoke [SHS] and gas stove emissions) sources. Elimination of SHS through smoking cessation and home smoking bans should always be considered a first-line indoor environmental intervention for children with asthma. Technological improvements have been made in the efficacy of high-efficiency particulate air (HEPA) particle filtration designed to remove targeted indoor air pollutants, such as fine particulate matter (PM 2.5 ). 61 Other than replacement of gas stoves with electric stoves, fewer methods are currently available for indoor NO 2 reduction of indoor or outdoor origin. 62, 63 In homes with smokers, recent home-and schoolbased intervention trials in children report significant reductions in particulate matter with HEPA filter use (Table II) 64-89 but without reduction in indoor gases, without consistent reductions in markers of cigarette smoke, and with mixed success in improving child asthma symptoms. The efficacy in reducing indoor pollutants is dependent on room dimensions and building structure and conditions. Although air cleaners have been used as adjunct interventions in multipronged environmental intervention trials 69 that have been successful in reducing asthma symptoms, their independent contributions to health are uncertain, and the physical settings in which they might reduce exposure sufficiently to contribute to asthma control are not well defined.
Research priorities
Indoor fungi originate through penetration from both outdoor and indoor sources, especially in damp and water-damaged buildings. [90] [91] [92] They have a multitude of forms, properties, and components. Fungi and their irritant or toxicant components can have adverse airway irritant and allergenic properties, and asthma symptoms can occur in both subjects who are not sensitized and those who are sensitized to fungi. 93, 94 Mechanisms for the effects of individual fungal components and interactive effects with other indoor exposures on airway and immune responses are not well understood. Paradoxically, some observational birth cohort studies suggest that specific microbial communities or early-life diversity of microbial agents, including fungi, can protect against allergy development, 95 but this is not a justification for discouraging fungal remediation in waterdamaged homes or poorly maintained moldy homes.
In symptomatic patients with asthma, fungal prevention and remediation strategies and their success in reducing exposures or improving health in damp or water-damaged buildings can vary by housing stock, climatic region, and resident behaviors. New building materials, ventilation systems, and home furnishings, particularly those harboring humidity, can introduce new challenges requiring novel strategies to minimize fungal growth. Although a review of studies to reduce mold in buildings and assess health outcomes recommended ''better research, preferably with a randomized controlled study design and with more validated outcome measures,'' 66,96,97 imaginative study designs are needed to fit the extreme situations with which investigators and communities are at times confronted. In disasters with clear-cut mold damage, the health risks can be obvious, but building remediation solutions can be challenging. The post-Hurricane Katrina Head-off Environmental Asthma in Louisiana study reported improvement of asthma symptoms with implementation of a hybrid intervention with asthma counselors and environmental remediation, but in the midst of postdisaster changes, investigators could not disentangle the extent to which the active study environmental interventions were responsible for the observed fungal reduction or symptom improvement. 98 A variety of multipronged community-based strategies have been used to decrease indoor allergen exposures, 99 ,100 with varying success in reducing exposure and improving asthma control. This inconsistency might be due to variable levels of intensity of the intervention, provided resources, participant education, social resources, or adherence. More confounders include other changes in environmental exposures, differences in tailoring the interventions to individual sensitivities of the participants, baseline allergen levels, and effect modification of the intervention Although many studies have sampled and tested the efficacy of interventions in individual indoor homes, effects of the structure and building components of housing, including multiunit structures, on exposure are less well studied. In Northeastern and midAtlantic cities, asthma prevalence is often high in multifamily low-income housing sites, where multiple and interrelated housing-related exposures are present. A few studies have evaluated indoor environmental and respiratory health before and after alterations in single or multifamily homes that undergo ''green'' construction, renovation, or weatherization under construction guidelines aimed to conserve energy while maintaining adequate ventilation using ''environmentally friendly'' materials. Such studies take advantage of costly interventions already taking place but have the potential limitations of uncontrolled observational study designs. 67 In one Boston-based study asthmatic children living in green homes experienced substantially lower risk of asthma symptoms, hospital visits, and asthma-related school absences than children living in conventional public housing. 67 A study of green housing in the South Bronx 101 showed improvements in asthma symptoms and urgent care visits for asthma, and a Chicago-based study showed self-reported asthma symptom improvements. 102 However, given the variable application of green construction approaches, the potential risks of responding to financial pressures through reduction of air exchange or inadequate maintenance (even in new buildings), and study design limitations, uncertainty remains about which aspects of new construction can improve asthma. Table II offers a summary of selected published studies on exposure reduction and on associations between exposure reduction and asthma control.
d Well-designed (and, if feasible, blinded and controlled) trials to test the conditions under which free-standing air filtration systems, structural interventions, and other emerging building-level interventions reduce indoor pollutants, allergens, and other contaminants at home or in schools. This is a precondition to assessing whether exposure reduction improves respiratory health d Development of effective mold reduction strategies tailored to specific individual risk factors (eg, poorly controlled asthma) and building, geographic, and climatic factors d Tailoring of multipronged strategies for indoor exposure reduction to the specific physical and social situations of urban families and their housing situations. Effective strategies might require changes in physical infrastructure, as well as in building management practices and occupant behavior. d Assessment, with engagement of building management and construction engineers, of effects of new building approaches (including green building) and building characteristics (eg, humidity and structural integrity) on indoor exposures and health d Assessment of effects of housing policy interventions, such as housing mobility programs, on indoor exposures d For highly mobile populations or for populations with little control over the structure of their homes, testing of lowcost interventions easily transferable from home to home or interventions that can be applied to any home without the need for structural changes d Development of novel technologies for particle or gas filtration (including NO 2 reduction) in home and school environments d With community engagement, development of interventions that can be applied to low-income populations with limited resources, especially those with high mobility d All environmental interventions should include cost-benefit estimations.
INDOOR ENVIRONMENTAL INTERVENTIONS FOR PRIMARY PREVENTION OF ASTHMA
Primary prevention of asthma is an enviable goal that, if achieved, could reduce the prevalence of the disease. Of a large number of potentially modifiable risk factors for asthma development identified in the literature, 103 allergen exposure is one that has attracted considerable attention. 104, 105 Observational epidemiologic studies have identified early-life allergen exposures as risk factors for subsequent allergic sensitization, and early allergic sensitization is a major risk factor for asthma. 106 However, the concept of allergen avoidance for primary prevention of asthma has been challenged by investigators who argue that this approach is limited by (1) the ubiquitous nature of aeroallergens in some ecologic and cultural settings, (2) the dominance of genetic factors in influencing the course of asthma, (3) the importance of early priming by other factors (eg, microbes or microbial components, in utero smoking, and vitamin D), or, most recently, (4) the benefits from early allergen exposure as manifested by studies in food allergy and (5) the protective effect against wheezing of high aeroallergen exposure in the first years of life. Evidence for potential benefits of early exposure to allergens or their sources for allergic sensitization, wheeze, or asthma have been reported by observational birth cohort studies, including the Massachusetts-based Epidemiology of Home Allergens and Asthma Study, the Wisconsin Childhood Origins of Asthma Study, the Detroit Childhood Allergy Study, and the Urban Environment and Childhood Asthma study. 34, 56, 58, 107 Most of these observational studies report protective associations with early-life mammalian exposures, especially exposure to dogs, and associated allergens or microbes. The Urban Environment and Childhood Asthma data indicated that early-life multiple exposures, including cockroach and mouse, are protective, 34 whereas the Epidemiology of Home Allergens and Asthma Study found these 2 exposures to be risk factors. Multiple differences in cofactors and exposure levels might be responsible for the contrasts in these observational studies.
Dust mite allergen avoidance and prevention studies
Long-term follow-up in primary allergen prevention trials focused on house dust mite (HDM) reduction vary in terms of their success in asthma prevention (Table III) . [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] The first such study was the Isle of Wight primary prevention study, which recruited 120 children and used a multifaceted approach to reduce both common food allergen and HDM exposure during infancy, with follow-up extending to 18 years. This study has shown a consistent reduction of asthma, but not atopy, in the allergen avoidance group. [109] [110] [111] A multifaceted approach for infants with a family history of allergic disease was also tested in the Canadian Asthma Primary Prevention Study (Table III) . The intervention, which began during pregnancy, yielded mixed results, with a significant reduction in asthma, but not atopy, at 1, 2, and 7 years. At 15 years of age, the reduction in asthma risk was seen only in female subjects. 112, 113 The Manchester Asthma and Allergy Primary Prevention Study tested the effect of stringent indoor allergen avoidance measures in a relatively large (n 5 291) randomized controlled trial. 114 By age 3 years, HDM sensitization was more common in the intervention group, and there was no difference between the groups in physician-diagnosed asthma. 115, 116 Finally, in the Prevention and Incidence of Asthma and Mite Allergy study, 810 allergic mothers were enrolled during pregnancy and randomized to impermeable mattress and pillow covers or placebo covers. Apart from a reduction in asthma prevalence at age 2 years, no preventive effect on asthma or allergic sensitization up to 8 years was observed. [117] [118] [119] There are a number of explanations for the inconsistent findings across studies of HDM allergen avoidance. It might be that only a multifaceted intervention is effective. 122 Another potential explanation is that the baseline mite allergen levels in the Prevention and Incidence of Asthma and Mite Allergy study were so low that further reduction could not have significant clinical effect. 123 It is also possible but less likely that genetic variations in Isle of Wight and Canadian children made them more receptive to allergen avoidance 124 or that genes or environmental cofactors in or outside the home modify either the magnitude or even the direction of the response. Overall, interpretation of these findings is difficult because the relationships between the levels of allergen exposure and their biologic effects are not clear.
Other potentially modifiable environmental factors for asthma prevention
An explanation for protective associations with pets might be that the ecology of the home microbiome is affected by the presence of a pet, which in turn might influence the gastrointestinal microbiome of the infant. [125] [126] [127] Whether the microbial ecology of a child's home is affected by outdoor microbes brought in by the pet or by the pet's own microbiome is unknown (Fig 1) . 128 The mechanisms through which this protection can occur are unknown, but the role of the microbiome and its biochemical products as modulators of innate immune system responses that might suppress allergy is an area of intense focus. 34, 129 One recent animal model validated the Detroit birth cohort observation that pet dust could be protective against allergic responses.
130
Asthma disproportionately affects certain ethnic groups, and patterns of allergen and microbial exposure vary according to socioeconomic status, area of residence, and race or ethnicity. 131, 132 For example, non-Hispanic blacks and Hispanics in the US Northeast are more likely to be exposed to mouse and cockroach allergens (but less likely to be exposed to HDM, dog, and cat allergens) than non-Hispanic whites. 133 In addition, stressful experiences, such as home or community violence, can contribute to the high prevalence of asthma in these communities. [134] [135] [136] Such experiences can disturb stress regulation and thus adversely influence immune function and increase susceptibility to asthma. 137 Primary prevention studies in asthma should strive to account for relevant social, cultural, and demographic factors, as well as for the role of diet, stress, and other lifestyle factors. 138 Other potentially modifiable factors, such as micronutrients, antioxidants, and others, which are not considered classic environmental pollutants, allergens, or bioaerosols, are beyond the scope of this article. However, such factors are being actively investigated in the context of asthma prevention. [139] [140] [141] [142] [143] [144] [145] [146] [147] Research priorities d Additional observational and animal model validation studies to assess the role of dose, route, timing, and pattern of single or multiple exposures, as well as genetic inheritance, in determining the relation of exposure to allergy or asthma development; this will optimize the design of asthma prevention trials focused on allergen, pollutant, and microbial exposures. d Sufficiently powered observational study of multiple earlylife environmental influences on asthma and allergy development in diverse communities in the United States. The recent collaboration of US birth cohorts through the NIHsponsored effort Environmental Influences on Child Health Outcomes (ECHO) offers a unique opportunity to achieve this goal. ECHO will facilitate characterization of children manifesting a variety of asthma phenotypes or endotypes that might be differentially influenced by indoor environmental exposures.
148,149
d Studies to identify early patterns of the human microbiome and its metabolic output in the gastrointestinal tract, airways, and skin that are associated with the development of allergic diseases and how they are influenced by the indoor environment, including environmental microbes, their metabolic products, and their functional components d Randomized multifaceted environmental interventions for asthma prevention designed to account for each element of the intervention and for social, cultural, and other demographic factors d Randomized controlled trials that include primary prevention of asthma through stress reduction measures tailored to ethnic and cultural diversity and assessment of interactive effects of stress reduction with environmental interventions on asthma development 
INDOOR ENVIRONMENTAL INTERVENTIONS FOR ASTHMA MANAGEMENT
Although indoor environmental interventions aimed at reducing asthma morbidity have been more successful than those aimed at primary prevention of asthma, questions remain about their role in asthma management. Table II provides an overview of the most recent environmental intervention trials and highlights their findings and limitations in influencing exposure reduction and asthma control. Effective environmental interventions are typically multifaceted, tailored to the specific exposures and sensitivities of the target subject, and intensive. 69, 150 Publication bias leads to less publication of unsuccessful intervention trials, but the few that have been published suggest that singleallergen interventions and low-intensity efforts are ineffective. One such negative publication 151 exemplifies the challenge of translating an efficacious intervention from a tightly controlled clinical trial setting to a broader population: when the provision of allergen-proof mattress/pillow encasements to adults with asthma was tested in primary care, no effect was found with this untailored intervention. Although the study population was adults, the notion that health benefits observed in tightly controlled randomized controlled trials might not easily translate to more real-world settings is applicable to environmental interventions in children as well. In addition, families face a number of barriers to remediating environmental exposures, including costs, preferences, home ownership status, lifelong behavioral practices, and education. For example, low-income urban populations are highly mobile and have limited resources with which to address environmental concerns. Also, residents often do not control the structure of their buildings because they rent rather than those who own their homes.
The Inner-City Asthma Study (ICAS) might be the most successful environmental intervention study conducted to date; the intervention was targeted at specific allergen reduction in asthmatic children who were both sensitized and exposed to those allergens, but the intervention was also multifaceted, including integrated pest management targeted to specific allergen sensitivities, provision of HEPA vacuum cleaners, free-standing bedroom HEPA filter air cleaners, and allergen-impermeable mattress and pillow covers. Primary trial results reported in 2004 found that the environmental intervention group experienced significant and clinically meaningful reductions in a range of asthma outcomes compared with control subjects. 69 Benefits were seen up to 12 months after the environmental intervention, and cost-effectiveness analysis derived a cost of $750 to $1000 per year per family to implement, a cost they estimated was equivalent to the cost of midrange inhaled corticosteroid and albuterol for a child with moderately severe asthma. This translated to almost $28 per gained symptom-free day. 152 Because a multifaceted and patient-tailored intervention was tested in ICAS and direct measures of environmental tobacco smoke exposure reduction were not made, it is not possible to determine the relative contribution of individual components of the environmental intervention and exposure reduction to the successful outcome. Notably, both arms of ICAS (environmental intervention and physician feedback) were successful without other interaction with the health care systems, but optimally, environmental control trials should be designed in the context of optimal access to health care, access to medications, and appropriate clinical asthma management.
Research priorities
d Further define the role of environmental interventions in asthma management by conducting randomized, multifaceted clinical trials designed to account for each element of the intervention and for social, cultural, and other demographic factors d Determine the most feasible, cost-effective, and clinically effective approach to environmental interventions by conducting head-to-head comparisons of various forms of environmental intervention d Determine which environmental intervention components can be effectively implemented and the best approaches to implementation. Studies are needed that will test how to effectively implement optimal environmental control schemes into health care, public health policy, housing policy, and clinical practice.
Specific detailed research questions for each priority area in environmental interventions for asthma management described above are listed in Table IV . Addressing these research priorities will have clear implications for how health care providers, public health agencies, health care systems, communities, and insurers implement and support environmental intervention as an integral component of asthma management.
CONCLUSIONS
With a focus on indoor allergens, microbes, and pollutants, workshop participants assessed current methods and prioritized new method development for measurement of indoor environmental exposures potentially relevant to asthma development and asthma management. We assessed new insights into the biologic properties of many of these exposures and prioritized the needs for future elucidation of these properties. We reviewed the state of knowledge of the efficacy of targeted and multipronged environmental interventions in changing environmental exposures and the social and structural challenges in influencing environment interventions, with recommendations for future directions. Finally, we reviewed the efficacy of primary prevention trials to reduce asthma development by altering the indoor biologic or physical environment and the efficacy of trials to improve asthma management and asthma control by improving the indoor home or school environment. For each covered topic, the workshop offered recommendations on research priorities to inform the next generation of asthma prevention or asthma management trials that include environmental components. There was uncertainty as to whether efforts at primary intervention should include a trial of changes in the indoor environment. It is anticipated that the newly funded, US-wide NIH initiative ECHO, as well as complementary mechanistic studies with functional validation of observational findings, might further inform future directions. Ultimately, new trials and translation of trial findings into public policy will need to take into account the family, social, economic, and neighborhood context of participants and, for children with established asthma, their access to adequate health care, including appropriate asthma medications.
